[Federal Register Volume 76, Number 14 (Friday, January 21, 2011)]
[Notices]
[Page 3919]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-1245]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
AIDS Research Advisory Committee, NIAID.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: AIDS Research Advisory Committee, NIAID; AIDS 
Vaccine Research Subcommittee.
    Date: February 8-9, 2011.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: Providing information on follow-up studies to define the 
correlates of protection observed in the RV144 vaccine efficacy 
trial, and to discuss the use of recombinant adenovirus vectors in 
AIDS vaccine development.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Salon A-C, Bethesda, MD 20852.
    Contact Person: James A. Bradac, PhD, Program Official, 
Preclinical Research and Development Branch, Division of AIDS, Room 
5116, National Institutes of Health/NIAID, 6700B Rockledge Drive, 
Bethesda, MD 20892-7628, 301-435-3754, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 14, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-1245 Filed 1-20-11; 8:45 am]
BILLING CODE 4140-01-P